Associated Papers
Discriminating activating, deactivating and resistance variants in protein kinases.
Singh G et al.
Genome Medicine, 2025
41152984 (PubMed )
Supplement: 13073_2025_1564_MOESM2_ESM.xlsx › Table_S6
Rare Tumor-Normal Matched Whole Exome Sequencing Identifies Novel Genomic Pathogenic Germline and Somatic Aberrations.
Sprissler R et al.
Cancers, 2020
32570879 (PubMed )
Supplement: cancers-12-01618-s001.zip › cancers-817200-Supplementary_Materials3 › Supplementary_Table_S2.xlsx › Supplementary_Table_2
MERTK mutation update in inherited retinal diseases.
Audo I et al.
Human Mutation, 2018
A Comprehensive Review of Mutations in the MERTK Proto-Oncogene.
Parinot C et al.
Advances in Experimental Medicine and Biology, 2016
Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted Therapy.
Pan CX et al.
Plos One, 2015
26270481 (PubMed )
Supplement: pone.0134346.s006.xlsx › Supp_Table_3
Clinical characterisation of a family with retinal dystrophy caused by mutation in the Mertk gene.
Tschernutter M et al.
The British Journal of Ophthalmology, 2006
Mutations in MERTK, the human orthologue of the RCS rat retinal dystrophy gene, cause retinitis pigmentosa.
Gal A et al.
Nature Genetics, 2000
Genetic analysis of transcriptional activation and repression in the Tn21 mer operon.
Ross W et al.
Journal of Bacteriology, 1989
Select a paper to view details